BMS-181167-02

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBMS-181167-02
Drug Alias NameD4APIBMS-18116702
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSarcomaHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company
Active IndicationsN/A
Inactive IndicationsSarcomaHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A